跳至主要内容
临床试验/TCTR20210403001
TCTR20210403001尚未招募2 期

A comparison of accelerated hypofractionated radiotherapy versus standard hypofractionated radiotherapy in early-stage breast cancer: a randomized controlled trial

Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn university0 个研究点目标入组 384 人开始时间: 2021年4月3日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
384

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
Female

入选标准

  • 1.Women age > 18 years
  • 2.Early-stage invasive breast cancer (T1-2, N0, M0) and Ductal Carcinoma In Situ
  • 3.Post breast conserving surgery with negative surgical margins
  • 4.Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2

排除标准

  • 1.Received previous breast irradiation
  • 2.Received breast reconstruction
  • 3.Received neoadjuvant therapy
  • 4.Bilateral breast cancer
  • 5.Other malignancy before diagnosis which can interfere the treatment outcome
  • 6.Hereditary breast cancer
  • 7.Active connective tissue disease
  • 8.Pregnancy or lactation
  • 9.Unable or unwilling to give inform consent

研究者

发起方
Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn university

相似试验